Biotechnology

New patent expiration for the drug Merck Sharp DUTREBIS – DrugPatentWatch

[ad_1]

Copyright © DrugPatentWatch. Originally published in Recently expired patent for the drug Merck Sharp DUTREBIS

Annual Drug Patent Expiration for DUTREBIS
Annual Drug Patent Expiration for DUTREBIS

Dutrebis is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are five patents protecting this drug.

This drug has forty-six patent family members in thirty-four countries.

The generic ingredient in DUTREBIS is lamivudine; raltegravir potassium. Additional details are available on lamivudine; raltegravir potassium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published in Recently expired patent for the drug Merck Sharp DUTREBIS

[ad_2]

Source link

Related Articles

Back to top button